Unitedhealth Stock Target Price and Analyst Consensus


USD 545.00  1.12  0.21%   

The prevalent analyst and expert consensus on Unitedhealth is Buy with 16 strong buy estimates. The prevailing projected target price is 503.54 with 19 professional opinions. Some of the most common ways Unitedhealth Group analysts use to provide public buy-or-sell recommendation are financial statements evaluation and conference calls analysis. They also talk to Unitedhealth executives, vendors, and customers. Unitedhealth buy-or-sell recommendation and consensus module provides average expert sentiment on the projected Unitedhealth Group target price to derive its highest and lowest estimates based on target price volatility of 42.105. Also, please take a look at Macroaxis Advice on Unitedhealth to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
The current Gross Profit is estimated to increase to about 42.1 B, while Profit Margin is projected to decrease to 5.26. Unitedhealth Total Assets are most likely to increase significantly in the upcoming years. The last year's value of Total Assets was reported at 212.21 Billion. The current Current Assets is estimated to increase to about 66.6 B, while Accumulated Other Comprehensive Income is projected to decrease to (3.2 B).

Unitedhealth Target Price Consensus

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Unitedhealth target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts performance other than comparing it to the past results via a very sophisticated attribution analysis. Unitedhealth target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
Number of Opinions21
Lowered Outlook0
Raized Outlook1
Most Unitedhealth analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Unitedhealth stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Unitedhealth Group, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Unitedhealth Target Price Projection

Unitedhealth's current and average target prices are 545.00 and 503.54, respectively. The current price of Unitedhealth is the price at which Unitedhealth Group is currently trading. On the other hand, Unitedhealth's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Unitedhealth Market Quote on 17th of August 2022

Low Price541.57Odds
High Price547.71Odds


Target Price

Analyst Consensus On Unitedhealth Target Price

Low Estimate440.0Odds
High Estimate575.0Odds
Number of Analysts19
Standard Deviation42.105


Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Unitedhealth Group and the information provided on this page.

Unitedhealth Analyst Ratings

Unitedhealth's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Unitedhealth stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Unitedhealth's financials, market performance, and future outlook by experienced professionals. Unitedhealth's historical ratings below, therefore, can serve as a valuable tool for investors.

Analyst Consensus Breakdown

Average Consensus Estimates

About Unitedhealth Target Price Projections

Unitedhealth's target price is an analyst's projection of its future price. Price targets can be assigned to all types of securities, from complex investment products to stocks such as Unitedhealth Group and even bonds. If the target price is unavailable, it is most likely because there were not enough analyst opinions to come up with a consensus estimate. When setting a price target estimate, an analyst is trying to determine what the Stock is worth and where the price will be in a year from now. Generally, the target price of Unitedhealth depends on its intrinsic valuation, beta (i.e., risk over market), and overall volatility. Most analysts publish their price targets in research reports on specific companies, along with their buy, hold, or sell recommendations. Stock price targets are often quoted in the financial news media. Macroaxis uses multiple feeds to provide overall target price projection for Unitedhealth Group including its fundamental analysis.
 2019 2020 2022 (projected)
Long Term Debt to Equity0.640.590.54
Interest Coverage11.5513.4715.74

Additional Unitedhealth Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Unitedhealth is a key component of Unitedhealth valuation and have some predictive power on the future returns of a Unitedhealth.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Unitedhealth's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Unitedhealth in the context of predictive analytics.
LowEstimated ValueHigh
LowReal ValueHigh
LowNext ValueHigh
Estimates (9)
LowProjected EPSHigh
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Unitedhealth. Your research has to be compared to or analyzed against Unitedhealth's peers to derive any actionable benefits. When done correctly, Unitedhealth's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Unitedhealth Group.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Macroaxis Index
Invested over 30 shares
Tech Growth
Invested few shares
Also, please take a look at Macroaxis Advice on Unitedhealth to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. Note that the Unitedhealth Group information on this page should be used as a complementary analysis to other Unitedhealth's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Complementary Tools for Unitedhealth Stock analysis

When running Unitedhealth Group price analysis, check to measure Unitedhealth's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Unitedhealth is operating at the current time. Most of Unitedhealth's value examination focuses on studying past and present price action to predict the probability of Unitedhealth's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Unitedhealth's price. Additionally, you may evaluate how the addition of Unitedhealth to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
CEO Directory
Screen CEOs from public companies around the world
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Money Managers
Screen money managers from public funds and ETFs managed around the world
The data published in Unitedhealth's official financial statements usually reflect Unitedhealth's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Unitedhealth Group. For example, before you start analyzing numbers published by Unitedhealth accountants, it's critical to develop an understanding of what Unitedhealth's liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Unitedhealth's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Unitedhealth's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Unitedhealth's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Unitedhealth Group. Please utilize our Beneish M Score to check the likelihood of Unitedhealth's management to manipulate its earnings.